Innovations in practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention deficit/hyperactivity disorder diagnosis in children: a completed audit cycle by Hall, Charlotte L. et al.
Innovations in Practice: an objective measure of
attention, impulsivity and activity reduces time to
confirm attention deficit/hyperactivity disorder
diagnosis in children – a completed audit cycle
Charlotte L. Hall1, Kim Selby2, Boliang Guo1, Althea Z Valentine1, GemmaMWalker1
& Chris Hollis1,3
1Division of Psychiatry and Applied Psychology, CLAHRC, University of Nottingham, Nottingham, UK.
E-mail: Charlotte.Hall@nottingham.ac.uk
2Department of Community Paediatrics, MedwayMaritime Hospital, Kent, UK
3Developmental Psychiatry, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
Background: Diagnosing attention deficit/hyperactivity disorder (ADHD) in children and young people typi-
cally relies on clinical observation and subjective parent, teacher and self-reports. The subjective nature of
reports combined with contradictory or missing data can result in diagnostic uncertainty and delay. The aim of
this study was to assess whether the addition of an objective test of attention, impulsivity and activity (QbTest)
as an adjunct to standard ADHD assessment could accelerate the diagnostic process in routine National Health
Service (NHS) settings.Method: In a pre vs. post-test audit design, case records were examined in 40 cases diag-
nosed without the QbTest [pre-QbTest group] and 40 cases diagnosed with the QbTest [QbTest group], record-
ing the number of consultations until a confirmed ADHD diagnosis was reached. Results: Using Poisson
regression, significantly fewer clinician consultations (mean 2.18 vs. 3.05; p < .02) were required to confirm
the diagnosis of ADHD when the QbTest was used to augment assessment in comparison to standard assess-
ment as usual. Conclusions: The findings suggest that the addition of the QbTest to standard clinical assess-
ment may reduce time to diagnosis and potentially result in cost savings to the NHS. These preliminary data
suggest that there is a potentially clinically meaningful benefit of adding the QbTest to routine clinical ADHD
assessment and this should be examined next in the context of a randomised controlled trial.
Key Practitioner Messages
• ADHD assessment can be lengthy and heavily reliant on clinical interpretation of subjective reports from
parents, teachers and young people.
• This audit found adding the QbTest to standard clinical assessment of ADHD significantly reduces the num-
ber of clinician consultations required to confirm a diagnosis.
• First data to suggest that the QbTest may facilitate standard ADHD assessment, resulting in rapid ADHD
diagnosis, particularly in cases of missing or conflicting rating scales.
• Future research is required to establish the utility of the QbTest to reduce time to accurate diagnosis and
further investigate the effect of this on patient outcome and costs to the NHS.
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Introduction
The assessment of attention deﬁcit/hyperactivity dis-
order (ADHD) in children typically relies on the clini-
cian’s judgement and the integration of various forms
of subjective information, such as parent, teacher and
the young person’s report. This process is heavily reli-
ant on subjective interpretation and can be hindered
when reports are not completed or contain contradic-
tory evidence. The assessment of ADHD is further
complicated by a high co-occurrence with other
disorders, making a differential diagnosis difﬁcult,
increasing the number of clinic visits and resulting in
substantial expenditure for the National Health Ser-
vice (NHS) (King et al., 2006).
Adding objective measures of ADHD may help facili-
tate the diagnostic process. Continuous performance
tests (CPT) are neuropsychological tests that typically
involve the rapid presentation of visual or auditory stim-
uli. Participants are requested to respond to a target
stimulus but not respond to nontargets. In doing so, the
CPT measures the participant’s ability to sustain atten-
tion and inhibit responses (impulsivity). There are sev-
eral well-validated CPTs (Conners, 2000; Forbes, 1998;
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Sandford & Turner, 2002) and previous research has
demonstrated that children with ADHD perform worse
on these tasks than children without ADHD (Losier,
McGrath, & Klein, 1996). However, a limitation of the
traditional CPT is it does not measure the patient’s activ-
ity level, a core symptom of ADHD.
The QbTest (Qbtech Ltd) is one neuropsychological
test that has been designed to measure the three core
symptom domains of ADHD: attention, impulsivity and
activity. The QbTest combines a computerised CPT with
an infrared motion capture of head movement to mea-
sure activity during the task. The QbTest requires partic-
ipants to respond to an infrequently presented stimulus
(by pressing a button), but ignores all other stimuli.
QbTest provides information on each of the three symp-
tom domains of ADHD and provides a summary report
based on deviation from a normative age and gender
data set. The QbTest has been approved by the United
States Food and Drug Administration (ref: K13382) and
although it is not a stand-alone diagnostic tool, several
UK NHS ADHD clinics have incorporated the assess-
ment as an adjunct to standard clinical practice. QbTest
is easy to administer, with simple participant instruc-
tions. Research has demonstrated the QbTest can differ-
entiate ADHD children from normative controls (Oades,
Myint, Dauvermann, Schimmelmann, & Schwarz,
2010), with sensitivity and speciﬁcity of around 90%
(Ulberstad, 2012, Unpublished data). Other research
suggests the addition of the QbTest to ADHD assessment
can improve clinical decision making. For example, Vogt
and Shameli (2011) found that children who were diag-
nosed with the addition of the QbTest to standard
assessment practice were less likely to receive a changed
diagnosis 1-year later than those diagnosed without the
addition of the QbTest.
A clinically important question is whether using
QbTest reduces the overall time and number of clinic vis-
its required to make correct ADHD diagnosis. Despite
the adoption of QbTest in several clinics, to date no
research has investigated this possibility. The aim of this
audit was to assess whether the addition of the QbTest
to standard clinical assessment reduced number of vis-
its to reach a diagnosis in routine NHS settings.
Methods
A total of 80 patient records were retrospectively examined in
a community paediatric ADHD clinic in Medway NHS Founda-
tion Trust. Case notes were accessed by a member of the
Trust’s clinical team (KS). The Trust introduced QbTest in July
2012. The baseline audit was conducted on 40 new cases
referred to the clinic prior to the introduction of QbTest
between June and December 2011 (pre-QbTest group). This
time period was selected to reﬂect the most current practice
up to the introduction of the QbTest, but prior to clinicians’
having any practice using QbTest. The reaudit was conducted
on 40 new cases referred between August 2012 and April
2013 (QbTest group) to reﬂect clinical practice directly after
installation of the QbTest (QbTest group). The time period for
both groups was selected to allow 40 cases to have been diag-
nosed. During this time period, there was no change to the
assessment process, except the QbTest. Methods of acquiring
parent and teacher information, and the quantity and quality
of information, remained unchanged, as did members of the
clinical and administration team. All clinicians were experi-
enced in ADHD assessment, with at least 4 years of clinical
practice at the time of the ﬁrst audit.
Inclusion criteria
Patient ﬁles were selected using a random-number generator
(Schulz & Grimes, 2002). Case notes were included if the case
had received a primary diagnosis of ADHDwithin the time frame
speciﬁed. For the reaudit, cases were also only included if they
had received a QbTest as part of their diagnostic assessment.
No cases in the baseline audit had undergone a QbTest. If a ﬁle
was excluded, the next eligible ﬁle along was used. All diagnoses
were made according to the ICD-10 criteria for Hyperkinetic
Disorder (F90) which broadly equivalent to severe combined
subtype ADHD in DSM-IV and DSM-5. A standardised audit
tool was used to record the diagnosis and number of clinician
consultations that each child had before the diagnosis of ADHD
was conﬁrmed.
Forty case notes were included for both the baseline and
reaudit, resulting in a total of 80 records. Standard assessment
within the Trust involves sending out the Strength & Difﬁculties
Questionnaire (SDQ; Goodman, 1997) to parents and teachers
alongside a school information form. At ﬁrst consultation, the
child’s developmental history is taken, the Conners’ parent and
teacher rating scales (Conners, Sitarenios, Parker, & Epstein,
1998a, 1998b) are sent out and the SDQ and school information
form is reviewed by the clinician. For each group, additional
consultations were made as necessary to make a diagnosis. For
cases diagnosed in the QbTest group, the QbTest was con-
ducted by a nurse prior to the patient’s clinical consultation.
Clinicians were provided with the QbTest result at the second
appointment. Qbtech provides training to all clinicians upon
installation of the QbTest; this includes multiple practice tests,
discussions and demonstrations. Qbtech clinical advisors
ensure that every clinician has reached a good standard of test
interpretation before they are considered competent to interpret
test results alone. In addition, clinical advisors are always avail-
able to offer additional test interpretation support when
required. It is stressed that the QbTest is not considered a stan-
dalone ADHD assessment and should be used to compliment
rating scales and clinical interviews and interpreted within the
clinical context by qualiﬁed healthcare professionals only.
Given this was a clinical audit conducted by staff within the
Trust for purposes of service evaluation; ethical approval was
not required.
Analysis
A Poisson regression was conducted to compare the mean num-
ber of clinician consultations needed to reach a diagnosis
between the Pre-QbTest (baseline audit) and QbTest (reaudit)
group. Incidence rate ratio was reported as measure of group
difference with a 95%Conﬁdence Interval. STATA 13 (StataCorp
LP, TX, USA) was used to conduct descriptive statistics and
Poisson regressionmodelling.
Results
The pre-QbTest group consisted of 32 boys (80%) and 8
girls (20%), with a mean age of 8.1 years (SD = 2.4 years
range: 4.5–14.6 years); the QbTest group consisted of 28
boys (70%) and 12 girls (30%), with a mean age of
9.2 years (SD = 2.3 years, range: 6.2–13.10 years). All
children had received a primary diagnosis of ADHD
(ICD-10, F90). Children in the QbTest group were
slightly older than those in the pre-QbTest group
(t(39) = 2.23, p = .03); there was no difference in gen-
der between the two groups (v² = .730, p = .55). In the
pre-QbTest group, 15 children also received a secondary
diagnosis: six children received a secondary diagnosis of
autism spectrum disorder (ASD), 2 ASD and tic disorder,
2 ASD and dyspraxia, 1 ASD and obsessive compulsive
disorder, 1 oppositional deﬁance disorder, 1 sensorineu-
ral deafness, 1 mild epilepsy, 1 Tourette’s syndrome. In
the QbTest group, 13 children received a secondary
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diagnosis: seven children received a secondary diagnosis
of ASD, 1 Tourette’s syndrome, 1 sensory processing dis-
order, 1 mild speech and language disorder, 1 emotional
difﬁculties, 1 dyslexia and 1 learning difﬁculties.
Table 1 shows the number of clinician consultations
needed to reach an ADHD diagnosis for both groups. For
both groups, most diagnoses were made at the second
consultation. However, for the pre-QbTest group 55%
(22 patients) required more than two consultations, in
the QbTest group only 18% (9 patients) required two or
more consultations to conﬁrm an ADHD diagnosis and
all diagnoses were made by the fourth consultation.
Poisson regression (Table 2) showed that the children
in the QbTest group needed signiﬁcantly fewer clinician
consultations to reach a diagnosis (average two consul-
tations) than children in the pre-QbTest group (average
three consultations).
The cost of a consultation within the Trust at the time
of audit equated to £108.00. A single QbTest cost the
Trust £31.00 (including the cost of the test as a propor-
tion of the lease fee, and a 30 min nurse-led appoint-
ment to conduct the test). As such, the total cost spent
on ADHD assessment in the pre-QbTest group equated
to £13,176, compared to £10,636 in the QbTest group,
equating to saving of £2,540. It should also be noted that
as the QbTest equipment is leased to clinics, there is no
additional start-up cost.
In cases where ﬁve or more clinician consultations
were required to make a diagnosis, the responsible clini-
cians were investigated the reasons behind the delay in
diagnosis. For 4/6 (66.6%) of cases, inconclusive or dis-
crepancy outcomes from clinical rating scales were cited
as the primary reason for delay, one case (17.0%) cited
complex comorbidities and one (17.0%) clinician reluc-
tance to make a diagnosis. We chose only to seek clariﬁ-
cation from clinicians with ﬁve or more consultations to
make diagnosis, as given the often complex nature of
ADHD it would not be atypical to require a few consulta-
tions to conﬁrm a diagnosis (see Table 1). Clinicians
were investigated how the QbTest helped to aid
diagnosis, responses included: the ability to compare
the child’s performance against a normed data set, the
opportunity to directly observe the child’s behaviour
while performing a task and the provision of an objective,
graphical report to compare to subjective reports.
Discussion
To assess whether the QbTest decreased number of
clinic visits needed to reach an ADHD diagnosis, we com-
pared the number of clinician consultations required to
reach a diagnosis in randomly selected cases who were
diagnosed with (QbTest group) and without (pre-QbTest
group) the QbTest. Our ﬁndings reveal a signiﬁcant
reduction in the number of clinician consultations, from
three to two consultations on average, required to con-
ﬁrm a diagnosis when the standard assessment proce-
dure was supplemented with a QbTest. Based on these
audit ﬁndings, it would be unwise to draw deﬁnitive con-
clusions; however, these preliminary data suggest that
the QbTest may facilitate standard ADHD assessment
and result in more rapid ADHD diagnosis in children,
particularly in cases of missing or conﬂicting rating
scales. The time and cost savings described here are
likely to be clinically important if conﬁrmed by a ran-
domised controlled trial. In turn, rapid accurate assess-
ment could facilitate appropriate treatment onset and
improve patient outcomes. It could be argued that the
pre-QbTest was a more complex client group, with a
slightly higher comorbidity of ASD (10%). However, the
10% difference in ASD is unlikely to explain the signiﬁ-
cant increase in the number of patients diagnosed by the
second appointments in the QbTest group (from 18%
pre-QbTest to 55% after the introduction of QbTest).
These ﬁndings support and extend previous research,
demonstrating the utility of the QbTest to aid ADHD
assessment in children. Previous research has indicated
that QbTest can differentiate ADHD from healthy con-
trols (Oades et al., 2010; Ulberstad, 2012, unpublished
data) and result in improved clinical decision making
(Vogt & Shameli, 2011). This current study is the ﬁrst to
show this improved decision making may result in a
reduction in clinical consultations and cost saving to
NHS practice.
A limitation of the study was that the ADHD diagnoses
were not independently veriﬁed and it is not known if
QbTest also facilitated the exclusion of an ADHD diagno-
sis in non-ADHD cases referred for ADHD diagnostic
assessment, limiting the comprehensiveness of these
ﬁndings. Our ﬁndings are limited to the practice of one
NHS Trust and a relatively small sample size, and our
conclusions should be interpreted within these method-
ological constraints. Despite this, these ﬁndings repre-
sent the ﬁrst insight into the potential of the QbTest to
Table 1. Number of clinician consultations until a diagnosis was reached in the Pre-QbTest and QbTest group
Number of children in which an ADHD diagnosis was made at respective consultation
1st consult (%) 2nd consult (%) 3rd consult (%) 4th consult (%) 5th consult (%) 6th consult (%) 7th consult (%)
Pre-QbTest
group
4 (10.0) 14 (35.0) 7 (17.5) 9 (22.5) 4 (2.9) 1.0 (2.5) 1 (2.5)
QbTest group 4 (10.0) 27 (67.5) 7 (17.5) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Consult = consultation. Percentages are reported in parentheses.
Table 2. Poisson regression comparison of number of clinician
consultations until diagnosis
Mean
(min, max
consultation)
Total number
of consultations
to make 40
diagnoses
Poisson
Regression
IRR (95%CI)
Pre-QbTest
group
3.05 (1, 7) 122 0.71 (0.54, 0.94),
p = .02
QbTest
group
2.18 (1, 4) 97
CI = Confidence Interval.
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streamline clinical practice and produce a clinically
important time and cost saving to the NHS. This result
should be used to inform a future randomised controlled
trial comprising a full economic analysis (Hall et al.,
2014). Strengths to this audit include the similar compo-
sition of children in each group and the random selection
of cases. We stress the need for further randomised
studies in a larger number of clinical settings to estab-
lish whether the QbTest does facilitate both accurate
and speedy diagnosis of ADHD and exclusion of ADHD
in non-ADHD cases in routine NHS clinics (Hall et al.,
2014).
Conclusion
The implementation of QbTest as an adjunct to standard
clinical assessment of ADHD in children reduced the
number of clinician consultations required to reach an
ADHD diagnosis. The clinical utility of the QbTest to
streamline and improve ADHD practice is worthy of more
rigorous clinical trials.
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